Thursday, January 15, 2026
HomeTagsDaiichi Sankyo

Tag: Daiichi Sankyo

Life Sciences

Lunit and Daiichi Sankyo Partner to Accelerate AI-Driven Biomarker Discovery in Oncology

Lunit Partnering with Daiichi Sankyo to Bring AI-Powered Pathology Analysis into Two of Daiichi Sankyo’s Oncology Research and Development Programs to Facilitate Faster Biomarker...
Healthcare

RevolKa Signed Master Service Agreement with Daiichi Sankyo

RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform (Norio Hamamatsu, President and CEO) signed a master service agreement with...
Healthcare

Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated advanced nonsquamous non-small cell lung cancer

AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients...

Recent Published

About Us

Discover the future of artificial intelligence at AITech365. Explore the latest AI news, delve into insightful interviews with industry experts, and stay informed about the most exciting and trending topics shaping the world of AI.

Latest

Popular

Quick Link

© 2025 AITech365. All Rights Reserved. Website Undertaking: Data Demand